Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Partners with Navigenics to Offer Personal Genetics Service

NEW YORK (GenomeWeb News) - Affymetrix and personal genetics startup Navigenics are teaming up to provide consumers with an understanding of their genetic predisposition for developing certain medical conditions.
Under that pact, which Affymetrix President Kevin King disclosed this week at the UBS Global Life Sciences Conference in New York, consumers will be able to go to the Navigenics website and order a saliva collection kit. The customer will then send the kit to Affymetrix’s CLIA lab, which will run a whole-genome screen and send the analysis to Navigenics. Then, Navigenics will provide the genetic-predisposition analysis to the customer via a secure, private web portal and offer genetic counseling.
Neither Affymetrix nor Navigenics, which has been funded by venture capital firms Kleiner Perkins and Sequoia Capital, has disclosed the cost of the service or its launch date, but Affymetrix officials said the firm is “realistic” and does not expect the alliance to provide it any significant revenue in the near term.
King added that the potential of combining electronic health records with the personal genetics service could eventually help healthcare providers and researchers better understand the role that environmental factors play in disease.
Navigenics is offering a similar service to that of another consumer genotyping startup, 23andMe. GenomeWeb Daily News sister publication BioArray News reported last month that Illumina had inked a partnership with 23andMe under which it would provide the company customized SNP arrays.
News of the alliance between Affymetrix and Navigenics was first reported in yesterday's issue of GenomeWeb Daily News sister publication BioCommerce Week.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.